Abstract
Some studies demonstrate that a large proportion of copy drugs contain lower levels of active substances and higher impurity levels than reference drugs. The number of copy drugs failing to meet internationally recognised quality criteria consequences of patients receiving lower doses of active substances than expected. In addition, possible clinical effect of impurities must be considered. Counterfeiting of drugs exhibits a significant and growing threat to human health and public safety.
Highlights
Counterfeit/copy drugs: patients safety in the heart
Some studies demonstrate that a large proportion of copy drugs contain lower levels of active substances and higher impurity levels than reference drugs
Counterfeiting of ly drugs exhibits a significant and growing threat to human health and public safety. It results an economic problem for innovator drug n manufacturers, undermining their revenues and reputation. o it negatively affects the confidence of the public in their medicines and the credibility of national health and enforcement e authorities
Summary
Counterfeit/copy drugs: patients safety in the heart Some studies demonstrate that a large proportion of copy drugs contain lower levels of active substances and higher impurity levels than reference drugs. The number of copy drugs failing to meet internationally recognised quality criteria consequences of patients receiving lower doses of active substances than expected.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.